Exer Labs is a technology company.
Exer Labs has raised $2.0M across 1 funding round.
Key people at Exer Labs.
Exer Labs was founded by Zaw Thet (Co-Founder and CEO).
Exer Labs has raised $2.0M in total across 1 funding round.
Key people at Exer Labs.
Exer Labs was founded by Zaw Thet (Co-Founder and CEO).
Exer Labs has raised $2.0M in total across 1 funding round.
Exer Labs's investors include Signia Venture Partners, David Ko, Mike Lee, Blisce, Preben Damgaard.
Exer Labs is an AI-powered digital health company based in Denver, Colorado, that develops a sensor-free platform using smartphone cameras and computer vision to provide real-time motion analysis for musculoskeletal (MSK) conditions and rehabilitation.[1][2][3] It serves healthcare providers, physical therapists, orthopedic surgeons, corporate wellness teams, fitness brands, and patients by enabling remote therapeutic monitoring (RTM), gait analysis, range of motion assessments, and personalized treatment plans, addressing issues like post-surgery recovery, chronic motion disorders, and fall risk in seniors.[1][2][4][5] The platform holds FDA Class II clearance, supports billing and electronic health records access, and has raised $11 million total ($4.5M in prior seeds + $6.5M in 2023), emerging from semi-stealth to expand tools amid growing demand for AI-driven remote care.[1][3]
Growth momentum includes launches of apps like Gait (for rapid gait metrics in seniors, athletes, and workplaces), Physio, Studio, and Range of Motion since 2021, plus products like Exer Scan, Exer Health, and Exer Hands for hybrid care pathways, with recent 2025 clinical validation studies presented at ASSH and CNS conferences.[3][4][5]
Founded in 2019 by Zaw Thet (CEO), Exer Labs emerged from the need to innovate in the "big, ugly, messy" U.S. healthcare system using AI and computer vision for remote patient monitoring without hardware sensors.[1][2] Thet, drawing on expertise in AI applications, collaborated with FDA, CMS, and stakeholders over two years to validate real-time motion tracking via phone cameras for mobility assessments post-surgery or therapy.[1] Early traction built through seed funding ($4.5M across two rounds) and app launches starting in 2021 (Gait and Physio), expanding from orthopedic focus to broader MSK and motion disorders, with pivotal FDA Class II approval enabling prescriptions and reimbursements.[1][4][5] The company grew from semi-stealth, adding world-class surgeon advisors from Steadman Clinic and Colorado Sports Medicine in 2022, and joining the Digital Therapeutics Alliance.[5][6]
Exer Labs rides the wave of AI-enabled digital therapeutics and remote monitoring, accelerated by post-pandemic demand for hybrid care, value-based reimbursement (e.g., RTM codes), and MSK health crises like aging populations and workplace injuries.[1][2][4] Timing aligns with advances in edge computing and computer vision, allowing scalable, affordable tools amid labor shortages and rising healthcare costs—detecting issues early prevents escalations, optimizes referrals, and cuts unnecessary tests.[3][5] It influences the ecosystem by modernizing assessments for providers (orthopedics, PTs), enabling corporate wellness/fitness integration, and contributing to DTx standards via alliances, while FDA clearance positions it for broader adoption in a $100B+ MSK market.[1][2][6]
Exer Labs is poised to scale its platform across large healthcare organizations, leveraging 2025 clinical validations and prior funding for deeper integrations in hybrid care, hand/wrist specialties, and predictive analytics.[3][5] Trends like AI regulatory tailwinds, CMS expansions for remote tech, and wearable alternatives will propel growth, potentially capturing shares in rehab, senior care, and sports medicine. Its influence may evolve from niche innovator to ecosystem enabler, powering data-driven outcomes in a fragmented healthcare system—watch for partnerships with EHR giants or enterprise pilots to drive the next revenue leap.[1][3]
Exer Labs has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in May 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2019 | $2.0M Seed | Signia Venture Partners, David Ko, Mike Lee, Blisce, Preben Damgaard |
